Publications

Aptar Continues to Provide Essential Products During COVID-19 Pandemic

We are pleased to share a letter from our CEO, Stephan Tanda, outlining Aptar’s COVID-19 priorities including the health and safety of our people and the continuity of production.

6 Nov 2020

We are rigorously monitoring the ongoing COVID-19 situation across the globe, including the recent rise in confirmed cases in many countries.

We invite you to click here to read a letter to our customers and partners from Aptar CEO, Stephan Tanda, which provides a summary of our ongoing actions as a partner in the fight against COVID-19.

Our priorities remain the health and safety of our people and the continuity of production so that we continue to deliver on our purpose to provide the drug delivery and consumer dispensing solutions that millions of people count on each day.

As a trusted partner to many of the world’s leading brands, we are committed to maintain our supply and increase capacity where needed.

We are here for you.

Back To Top